Pamela Tenaerts

Electronic consent can personalize the patient experience in clinical trials and even improve retention. At Medable, where I am CSO, we’re committed to driving the adoption of this transformative technology.
FDA
However, a lack of regulatory harmonization risks undermining the effective implementation of these technology-driven approaches.